Clinical Trials Browser

Alzheimer Disease × 30 days × Clear all

Agnosia, Alzheimer Disease, Pain

NCT03431896 2026-03-12

MED-hATTR

Amyloidosis, Hereditary, Transthyretin-Related, Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Amyloid Neuropathies, Familial

NCT04270175 2026-02-27

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Phase 2 Active not recruiting

15 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

11 enrolled

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT05894954 2026-02-18